Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi

B Tanabe Pharma America Remains Focused on Rare Disease Innovation and Addressing Unmet Patient Needs JERSEY CITY, N.J., April 1, 2026 /PRNewswire/ — Tanabe Pharma America,…
posteditor
posteditor
Articles: 16137

Other News